Close

PTC Therapeutics (PTCT) Reiterated Buy at Wedbush

September 23, 2013 12:42 PM EDT Send to a Friend
Wedbush maintained an Outperform on PTC Therapeutics (NASDAQ: PTCT) with a price target of $55.00. Analyst Christopher N. Marai thinks ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login